Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 20 April, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 532067 | NSE: 3BBLACKBIO

Fundamental Analysis of 3B Blackbio DX Ltd

Basic Stock Data

Last Updated: April 19, 2024, 10:38 am

Market Cap 570 Cr.
Current Price 759
High / Low924/390
Stock P/E20.5
Book Value 278
Dividend Yield0.33 %
ROCE19.1 %
ROE16.0 %
Face Value 10.0

Data Source: screener.in

Competitors of 3B Blackbio DX Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Bhagiradha Chemicals & Industries Ltd 1,953 Cr. 1,8892,008/1,10088.8 3080.21 %22.0 %18.4 % 10.0
Aimco Pesticides Ltd 99.2 Cr. 104145/89.0 41.90.97 %0.66 %4.51 % 10.0
Phyto Chem (India) Ltd 15.4 Cr. 35.855.6/29.5 20.20.00 %7.55 %1.90 % 10.0
UPL Ltd 36,604 Cr. 488760/448 3852.05 %14.3 %13.4 % 2.00
Bhaskar Agrochemicals Ltd 33.4 Cr. 64.078.1/33.025.6 25.40.00 %12.2 %1.93 % 10.0
Industry Average7,741.00 Cr516.1622.88156.100.65%11.34%8.03%8.40

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales42.6918.8832.6715.2214.3618.4011.6917.3114.7318.1114.2819.1817.67
Expenses17.7210.3714.469.227.3912.486.518.137.4210.657.8411.398.80
Operating Profit24.978.5118.216.006.975.925.189.187.317.466.447.798.87
OPM %58.49%45.07%55.74%39.42%48.54%32.17%44.31%53.03%49.63%41.19%45.10%40.62%50.20%
Other Income1.581.191.551.941.541.871.241.962.881.152.962.752.63
Interest0.030.040.030.060.03-0.020.030.070.050.040.020.040.03
Depreciation0.230.110.150.180.170.170.170.240.250.210.190.240.32
Profit before tax26.299.5519.587.708.317.646.2210.839.898.369.1910.2611.15
Tax %25.14%25.55%23.70%23.64%21.06%36.91%24.12%23.27%22.04%37.80%21.55%26.02%23.68%
Net Profit19.677.1014.945.886.564.824.728.317.725.207.217.588.51
EPS in Rs22.988.2417.536.857.665.535.3911.208.966.019.7110.4611.61

Last Updated: April 10, 2024, 3:50 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: April 5, 2024, 3:13 pm

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales212022191716232329227816269
Expenses20192118161418162077443339
Operating Profit111123579150372931
OPM %5%6%6%7%9%16%23%31%32%66%46%47%44%
Other Income0000000123779
Interest1111111000000
Depreciation0000000111111
Profit before tax0100015710152433539
Tax %104%34%14%23%23%19%24%25%23%25%26%27%
Net Profit-000001358114322628
EPS in Rs-0.020.620.590.360.511.765.358.1810.24151.6642.8934.5537.79
Dividend Payout %0%0%0%0%0%17%9%6%7%6%24%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)200.00%66.67%60.00%1325.00%-71.93%-18.75%
Change in YoY Net Profit Growth (%)0.00%-133.33%-6.67%1265.00%-1396.93%53.18%

Growth

Compounded Sales Growth
10 Years:12%
5 Years:22%
3 Years:29%
TTM:11%
Compounded Profit Growth
10 Years:52%
5 Years:50%
3 Years:50%
TTM:20%
Stock Price CAGR
10 Years:62%
5 Years:56%
3 Years:35%
1 Year:81%
Return on Equity
10 Years:39%
5 Years:43%
3 Years:44%
Last Year:16%

Last Updated: April 16, 2024, 1:11 pm

Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital6666666677779
Reserves334445121625125146164200
Borrowings6678896642321
Other Liabilities77776668959374115
Total Liabilities222324252426303645194192214225
Fixed Assets4444334445788
CWIP0000000000000
Investments00000000159939296
Other Assets18192021212226324013093114122
Total Assets222324252426303645194192214225

Reserves and Borrowings Chart

Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 0-10011247983723
Cash from Investing Activity -10-0-0-0-0-1-1-1-70-2812
Cash from Financing Activity 1-00-0-1-00-11-2-15-5
Net Cash Flow1-10-00012726-630

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow-5.00-5.00-6.00-7.00-6.00-6.00-1.001.005.00148.0034.0027.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

3B Blackbio DX Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days18022021326228332125929025256136200
Inventory Days109149120145143175
Days Payable165220189218203186
Cash Conversion Cycle12414914418822331025929025256136200
Working Capital Days16721421827431237730835130267169248
ROCE %7%8%7%7%7%13%24%28%31%162%27%19%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters38.35%38.35%38.35%38.43%38.43%38.43%38.43%38.43%38.43%38.43%38.43%38.43%
FIIs1.10%1.47%0.54%1.23%1.64%1.64%1.64%2.11%2.54%3.06%3.16%3.38%
DIIs0.00%0.09%0.08%0.08%0.08%0.08%0.00%0.00%0.00%0.00%0.82%1.18%
Public60.55%60.09%61.03%60.26%59.85%59.85%59.94%59.47%59.02%58.50%57.60%56.99%
No. of Shareholders9,77210,54116,25116,75616,46816,31615,41513,79813,13612,41610,51310,088

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)34.5543.40151.6610.258.20
Diluted EPS (Rs.)34.5543.40151.6610.258.20
Cash EPS (Rs.)35.7743.88152.8210.989.06
Book Value[Excl.RevalReserv]/Share (Rs.)261.50229.69197.9245.7335.60
Book Value[Incl.RevalReserv]/Share (Rs.)261.50229.69197.9245.7335.60
Revenue From Operations / Share (Rs.)82.54107.65302.6638.5436.42
PBDIT / Share (Rs.)48.5558.73204.0714.5712.46
PBIT / Share (Rs.)47.4057.84203.2513.8611.60
PBT / Share (Rs.)47.1357.69202.9413.4210.88
Net Profit / Share (Rs.)34.6242.98152.0010.268.20
NP After MI And SOA / Share (Rs.)34.6242.98152.0010.268.20
PBDIT Margin (%)58.8154.5667.4237.8034.20
PBIT Margin (%)57.4253.7267.1535.9531.85
PBT Margin (%)57.1053.5967.0534.8129.86
Net Profit Margin (%)41.9439.9250.2126.6222.51
NP After MI And SOA Margin (%)41.9439.9250.2126.6222.51
Return on Networth / Equity (%)15.1421.0486.2323.9323.29
Return on Capital Employeed (%)17.7624.73101.1328.3028.62
Return On Assets (%)12.1116.7658.8317.1414.42
Long Term Debt / Equity (X)0.010.010.010.040.09
Total Debt / Equity (X)0.010.010.010.100.27
Asset Turnover Ratio (%)0.300.130.380.410.42
Current Ratio (X)8.054.822.764.823.08
Quick Ratio (X)7.494.382.644.322.60
Inventory Turnover Ratio (X)2.332.662.682.482.26
Dividend Payout Ratio (NP) (%)0.000.000.0020.1718.06
Dividend Payout Ratio (CP) (%)0.000.000.0018.8516.35
Earning Retention Ratio (%)0.000.000.0079.8381.94
Cash Earning Retention Ratio (%)0.000.000.0081.1583.65
Interest Coverage Ratio (X)183.32413.58669.5332.6717.21
Interest Coverage Ratio (Post Tax) (X)131.73303.65499.6823.9912.33
Enterprise Value (Cr.)278.94248.35196.4350.6351.32
EV / Net Operating Revenue (X)4.513.080.861.752.20
EV / EBITDA (X)7.675.641.284.646.45
MarketCap / Net Operating Revenue (X)5.043.170.941.882.07
Retention Ratios (%)0.000.000.0079.8281.93
Price / BV (X)1.821.671.621.692.14
Price / Net Operating Revenue (X)5.043.170.941.882.07
EarningsYield0.080.120.530.140.10

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 914.85

The stock is undervalued by 20.53% compared to the current price ₹759

Calculation basis:

  • Fair value = (P/E Ratio * (Return on Equity / 100) * Book Value) * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 28.33%, which is a positive sign.
  2. The company has higher reserves (54.69 cr) compared to borrowings (5.23 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (48.38 cr) and profit (22.54 cr) over the years.
  1. The stock has a high average Working Capital Days of 250.58, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 194.25, which may not be favorable.

Stock Analysis

  • Based on the analysis of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 3B Blackbio DX Ltd:
    1. Net Profit Margin: 41.94% (Higher values are generally favorable)
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 17.76% (Industry Average ROCE: 11.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 15.14% (Industry Average ROE: 8.03%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 131.73 (Higher values, preferably > 2, are recommended)
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 7.49 (Higher values, preferably > 1, are recommended)
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 20.5 (Industry average Stock P/E: 22.88)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01 (Lower values, preferably < 1, are preferred)
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    While these metrics suggest potential opportunity, it's essential to conduct thorough research or seek advice from financial experts before making any investment decisions.
    Stock Rating: ★★★★★

About the Company

Kilpest India Ltd. is a Public Limited Listed company incorporated on 27/05/1972 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24211MP1972PLC001131 and registration number is 001131. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company’s Total Operating Revenue is Rs. 15.52 Cr. and Equity Capital is Rs. 7.49 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Agro Chemicals/Pesticides7-C, Industrial Area, Govindpura, Bhopal Madhya Pradesh 462023kilpestbpl@yahoo.co.in
http://www.kilpest.com
Management
NamePosition Held
Mr. Dhirendra DubeyChairman & Managing Director
Mr. N K DubeyWholeTime Director & CFO
CA. Shabbar HusainIndependent Director
Mr. Abdul Moin KhanIndependent Director
Mrs. Mithala DubeyDirector
Mr. Harihar Prasad ThapakIndependent Director

3B BlackBio Dx Ltd. Share Price Update

Share PriceValue
Today₹758.65
Previous Day₹765.50

FAQ

What is the latest fair value of 3B Blackbio DX Ltd?

The latest fair value of 3B Blackbio DX Ltd is 914.85.

What is the Market Cap of 3B Blackbio DX Ltd?

The Market Cap of 3B Blackbio DX Ltd is 570 Cr..

What is the current Stock Price of 3B Blackbio DX Ltd as on 20 April 2024?

The current stock price of 3B Blackbio DX Ltd as on 20 April 2024 is 759.

What is the High / Low of 3B Blackbio DX Ltd stocks in FY 2024?

In FY 2024, the High / Low of 3B Blackbio DX Ltd stocks is ₹924/390.

What is the Stock P/E of 3B Blackbio DX Ltd?

The Stock P/E of 3B Blackbio DX Ltd is 20.5.

What is the Book Value of 3B Blackbio DX Ltd?

The Book Value of 3B Blackbio DX Ltd is 278.

What is the Dividend Yield of 3B Blackbio DX Ltd?

The Dividend Yield of 3B Blackbio DX Ltd is 0.33 %.

What is the ROCE of 3B Blackbio DX Ltd?

The ROCE of 3B Blackbio DX Ltd is 19.1 %.

What is the ROE of 3B Blackbio DX Ltd?

The ROE of 3B Blackbio DX Ltd is 16.0 %.

What is the Face Value of 3B Blackbio DX Ltd?

The Face Value of 3B Blackbio DX Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in 3B Blackbio DX Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE